Accelerant Holdings (ARX) Investor Relations Documents

Accelerant Holdings (ARX) investor relations documents from the company's IR site: 4 presentations, 27 press releases; latest deck 2026-05-12. Read in-app with summaries. First-party data.

Download PDF file, (opens in new window): Accelerant's Q1 2026 update reports $1.14B in Exchange Written Premium and $66M in Adjusted EBITDA, reflecting 16% and 70% year-over-year growth respectively.

Investor relations documents — source: company IR site
PublishedTypeDocument
2026-08-13Press releaseAccelerant Enters into Definitive Agreement to be Acquired by Thoma Bravo
2026-08-13Press releaseAccelerant Announces Second Quarter 2026 Results
2026-07-23Press releaseAccelerant Announces Date of Second Quarter 2026 Financial Results and Conference Call
2026-07-13Press releaseDownload PDF, Accelerant Announces Partnership With New Third-Party Capitalized Insurer WoodStar, July 13, 2026, (opens
2026-06-03Press releaseAccelerant to Present at William Blair’s 46th Annual Growth Stock Conference
2026-05-29Press releaseDownload PDF, Accelerant to Present at William Blair’s 46th Annual Growth Stock Conference, May 29, 2026, (opens in new
2026-05-13Press releaseAccelerant Announces First Quarter 2026 Results
2026-05-13Press releaseAccelerant Announces First Quarter 2026 Results
2026-05-13Press releaseAccelerant Announces Date of First Quarter 2026 Financial Results and Conference Call
2026-05-12PresentationDownload PDF file, (opens in new window)
2026-04-27Press releaseDownload PDF, Accelerant Announces Date of First Quarter 2026 Financial Results and Conference Call, April 27, 2026, (op
2026-03-31Press releaseAccelerant Completes CFO Transition
2026-03-19PresentationDownload PDF (opens in new window)
2026-03-19Press releaseAccelerant Announces Date of Fourth Quarter and Full Year 2025 Financial Results and Conference Call
2026-03-18Press releaseAccelerant Announces Fourth Quarter and Full Year 2025 Results
2026-02-26Press releaseAccelerant Announces Unaudited Preliminary Fourth Quarter and Full Year 2025 Financial Results
2026-02-24Press releaseDownload PDF, Accelerant Announces Leadership Updates Across Legal and Investor Relations, February 24, 2026, (opens in
2026-02-09Press releaseDownload PDF, Accelerant Announces Date of Fourth Quarter and Full Year 2025 Financial Results and Conference Call, Febr
2025-11-12PresentationDownload PDF (opens in new window)
2025-10-03Press releaseDownload PDF, Accelerant Announces Date of Third Quarter 2025 Financial Results and Conference Call, October 3, 2025, (o
2025-09-19PresentationDownload PDF (opens in new window)
2025-09-11Press releaseDownload PDF, Accelerant Announces Partnership With AF Specialty to Expand Risk Exchange Capacity, September 11, 2025, (
2025-08-13Press releaseDownload PDF, Accelerant Announces Date of Second Quarter 2025 Financial Results and Conference Call, August 13, 2025, (
2025-07-25Press releaseDownload PDF, Accelerant Holdings Announces Closing of Upsized Initial Public Offering and Full Exercise of Over-Allotme
2025-07-23Press releaseDownload PDF, Accelerant Holdings Announces Pricing of Upsized Initial Public Offering, July 23, 2025, (opens in new win
2025-07-15Press releaseDownload PDF, Accelerant Holdings Announces Launch of Initial Public Offering, July 15, 2025, (opens in new window)
2025-07-02Press releaseDownload PDF, Accelerant Holdings Announces Public Filing of Registration Statement for Initial Public Offering, July 2,
2025-04-22Press releaseDownload PDF, Accelerant Risk Exchange Adds QBE and Tokio Marine America to Expanding Network, April 22, 2025, (opens in
Press releaseAccelerant Completes CFO Transition
Press releaseAccelerant Announces Partnership With New Third-Party Capitalized Insurer WoodStar
Press releaseAccelerant Announces Leadership Updates Across Legal and Investor Relations

ARX overview · ARX earnings · ARX financials · ARX KPIs · ARX documents · ARX ownership · ARX peers

Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.